Trial Outcomes & Findings for Brain Injury Rehabilitation Improving the Transition Experience (NCT NCT03422276)
NCT ID: NCT03422276
Last Updated: 2025-03-12
Results Overview
The Participation Assessment with Recombined Tools - Objective 17 (PART-O-17) assesses participation in usual roles and social activities. There are 17 items with 0-5 response scales. Those items are combined and averaged into three domain subscale scores that range from 0-5: Productivity (3 items), Social Relations (7 items), and Out and About (7 items). The Averaged Total score, used here, is calculated by averaging the three domain scores. Higher values represent a better outcome.
COMPLETED
NA
1555 participants
This outcome will be assessed via self-report instrument from the patient participant 6 months after discharge from inpatient rehabilitation care.
2025-03-12
Participant Flow
Patient participants were recruited from 6 IPR facilities starting in Feb 2018 through Aug 2021. Caregivers (CG) of enrolled patients were recruited from the first patient enrollment through the end of patient participation. The final CG enrolled in February 2022. Patients could have more than one CG enrolled in the study due to changes in primary caregiver responsibility. Only one CG completed each follow up (max N at any follow up 591), but a total of 611 CG were enrolled throughout the study.
11 patients were enrolled but not randomized in the study for the following reasons: Determined to be ineligible, death, withdrew, and other. The majority (8) were determined to be ineligible. 8 caregivers were enrolled to patients that were not randomized. So a total of 19 of the 1555 enrolled patients and caregivers were not part of the randomized cohort.
Participant milestones
| Measure |
Rehabilitation Discharge Plan
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
Rehabilitation Discharge Plan - Caregivers
Caregivers of patients randomized to the Rehabilitation Discharge Plan (RDP) group
|
Rehabilitation Transition Plan - Caregivers
Caregivers of patients randomized to the Rehabilitation Transition Plan (RTP) group
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
462
|
463
|
296
|
295
|
|
Overall Study
COMPLETED
|
407
|
405
|
246
|
254
|
|
Overall Study
NOT COMPLETED
|
55
|
58
|
50
|
41
|
Reasons for withdrawal
| Measure |
Rehabilitation Discharge Plan
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
Rehabilitation Discharge Plan - Caregivers
Caregivers of patients randomized to the Rehabilitation Discharge Plan (RDP) group
|
Rehabilitation Transition Plan - Caregivers
Caregivers of patients randomized to the Rehabilitation Transition Plan (RTP) group
|
|---|---|---|---|---|
|
Overall Study
Withdrawal by Subject
|
21
|
25
|
14
|
16
|
|
Overall Study
Death
|
14
|
21
|
3
|
1
|
|
Overall Study
Discontinued, ineligible
|
4
|
3
|
0
|
0
|
|
Overall Study
Lost to Follow-up
|
15
|
8
|
13
|
4
|
|
Overall Study
Discontinued, researcher decided not in participant's best interest
|
1
|
0
|
1
|
0
|
|
Overall Study
Incarcerated prior to first follow-up
|
0
|
1
|
0
|
0
|
|
Overall Study
Discontinued, no longer caregiver for patient participant
|
0
|
0
|
10
|
3
|
|
Overall Study
Discontinued, for caregiver, death of patient participant
|
0
|
0
|
8
|
17
|
|
Overall Study
Discontinued, for caregiver, patient participant was determined to be ineligible
|
0
|
0
|
1
|
0
|
Baseline Characteristics
Patient and Caregiver participants were analyzed separately, so each group is presented in a separate row.
Baseline characteristics by cohort
| Measure |
Rehabilitation Discharge Plan
n=462 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=463 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
Rehabilitation Discharge Plan - Caregivers
n=309 Participants
Caregivers of patients randomized to the Rehabilitation Discharge Plan (RDP) group
|
Rehabilitation Transition Plan - Caregivers
n=302 Participants
Caregivers of patients randomized to the Rehabilitation Transition Plan (RTP) group
|
Total
n=1536 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Continuous
Patients
|
48 years
STANDARD_DEVIATION 20 • n=462 Participants • Patient and Caregiver participants were analyzed separately, so each group is presented in a separate row.
|
47 years
STANDARD_DEVIATION 20 • n=463 Participants • Patient and Caregiver participants were analyzed separately, so each group is presented in a separate row.
|
—
|
—
|
47 years
STANDARD_DEVIATION 20 • n=925 Participants • Patient and Caregiver participants were analyzed separately, so each group is presented in a separate row.
|
|
Age, Continuous
Caregivers
|
—
|
—
|
50 years
STANDARD_DEVIATION 15 • n=309 Participants • Patient and Caregiver participants were analyzed separately, so each group is presented in a separate row.
|
51 years
STANDARD_DEVIATION 13 • n=302 Participants • Patient and Caregiver participants were analyzed separately, so each group is presented in a separate row.
|
51 years
STANDARD_DEVIATION 14 • n=611 Participants • Patient and Caregiver participants were analyzed separately, so each group is presented in a separate row.
|
|
Sex: Female, Male
Female
|
134 Participants
n=462 Participants
|
114 Participants
n=463 Participants
|
218 Participants
n=309 Participants
|
225 Participants
n=302 Participants
|
691 Participants
n=1536 Participants
|
|
Sex: Female, Male
Male
|
328 Participants
n=462 Participants
|
349 Participants
n=463 Participants
|
91 Participants
n=309 Participants
|
77 Participants
n=302 Participants
|
845 Participants
n=1536 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
47 Participants
n=449 Participants • Difference for RDP and RTP is due to missing values. For RDP-Caregivers and RTP-Caregivers, this item was not collected.
|
29 Participants
n=452 Participants • Difference for RDP and RTP is due to missing values. For RDP-Caregivers and RTP-Caregivers, this item was not collected.
|
—
|
—
|
76 Participants
n=901 Participants • Difference for RDP and RTP is due to missing values. For RDP-Caregivers and RTP-Caregivers, this item was not collected.
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
402 Participants
n=449 Participants • Difference for RDP and RTP is due to missing values. For RDP-Caregivers and RTP-Caregivers, this item was not collected.
|
423 Participants
n=452 Participants • Difference for RDP and RTP is due to missing values. For RDP-Caregivers and RTP-Caregivers, this item was not collected.
|
—
|
—
|
825 Participants
n=901 Participants • Difference for RDP and RTP is due to missing values. For RDP-Caregivers and RTP-Caregivers, this item was not collected.
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=449 Participants • Difference for RDP and RTP is due to missing values. For RDP-Caregivers and RTP-Caregivers, this item was not collected.
|
0 Participants
n=452 Participants • Difference for RDP and RTP is due to missing values. For RDP-Caregivers and RTP-Caregivers, this item was not collected.
|
—
|
—
|
0 Participants
n=901 Participants • Difference for RDP and RTP is due to missing values. For RDP-Caregivers and RTP-Caregivers, this item was not collected.
|
|
Race/Ethnicity, Customized
Race · White
|
296 Participants
n=458 Participants • Difference is due to missing values in measure.
|
314 Participants
n=457 Participants • Difference is due to missing values in measure.
|
221 Participants
n=303 Participants • Difference is due to missing values in measure.
|
214 Participants
n=295 Participants • Difference is due to missing values in measure.
|
1045 Participants
n=1513 Participants • Difference is due to missing values in measure.
|
|
Race/Ethnicity, Customized
Race · Black
|
81 Participants
n=458 Participants • Difference is due to missing values in measure.
|
79 Participants
n=457 Participants • Difference is due to missing values in measure.
|
42 Participants
n=303 Participants • Difference is due to missing values in measure.
|
44 Participants
n=295 Participants • Difference is due to missing values in measure.
|
246 Participants
n=1513 Participants • Difference is due to missing values in measure.
|
|
Race/Ethnicity, Customized
Race · Hispanic
|
53 Participants
n=458 Participants • Difference is due to missing values in measure.
|
33 Participants
n=457 Participants • Difference is due to missing values in measure.
|
24 Participants
n=303 Participants • Difference is due to missing values in measure.
|
13 Participants
n=295 Participants • Difference is due to missing values in measure.
|
123 Participants
n=1513 Participants • Difference is due to missing values in measure.
|
|
Race/Ethnicity, Customized
Race · Other
|
28 Participants
n=458 Participants • Difference is due to missing values in measure.
|
31 Participants
n=457 Participants • Difference is due to missing values in measure.
|
16 Participants
n=303 Participants • Difference is due to missing values in measure.
|
24 Participants
n=295 Participants • Difference is due to missing values in measure.
|
99 Participants
n=1513 Participants • Difference is due to missing values in measure.
|
|
Region of Enrollment
United States
|
462 participants
n=462 Participants
|
463 participants
n=463 Participants
|
309 participants
n=309 Participants
|
302 participants
n=302 Participants
|
1536 participants
n=1536 Participants
|
|
Education Level
Less than High School
|
66 Participants
n=454 Participants • Differences are due to missing values.
|
59 Participants
n=457 Participants • Differences are due to missing values.
|
13 Participants
n=300 Participants • Differences are due to missing values.
|
11 Participants
n=293 Participants • Differences are due to missing values.
|
149 Participants
n=1504 Participants • Differences are due to missing values.
|
|
Education Level
HS Diploma or GED
|
161 Participants
n=454 Participants • Differences are due to missing values.
|
152 Participants
n=457 Participants • Differences are due to missing values.
|
85 Participants
n=300 Participants • Differences are due to missing values.
|
79 Participants
n=293 Participants • Differences are due to missing values.
|
477 Participants
n=1504 Participants • Differences are due to missing values.
|
|
Education Level
Some College
|
126 Participants
n=454 Participants • Differences are due to missing values.
|
118 Participants
n=457 Participants • Differences are due to missing values.
|
93 Participants
n=300 Participants • Differences are due to missing values.
|
84 Participants
n=293 Participants • Differences are due to missing values.
|
421 Participants
n=1504 Participants • Differences are due to missing values.
|
|
Education Level
College or more
|
101 Participants
n=454 Participants • Differences are due to missing values.
|
128 Participants
n=457 Participants • Differences are due to missing values.
|
109 Participants
n=300 Participants • Differences are due to missing values.
|
119 Participants
n=293 Participants • Differences are due to missing values.
|
457 Participants
n=1504 Participants • Differences are due to missing values.
|
|
Married/Partner, yes
|
159 Participants
n=458 Participants • Differences are due to missing values.
|
189 Participants
n=458 Participants • Differences are due to missing values.
|
193 Participants
n=303 Participants • Differences are due to missing values.
|
194 Participants
n=296 Participants • Differences are due to missing values.
|
735 Participants
n=1515 Participants • Differences are due to missing values.
|
|
Competitively employed, yes
|
268 Participants
n=456 Participants • Differences are due to missing values.
|
284 Participants
n=458 Participants • Differences are due to missing values.
|
202 Participants
n=302 Participants • Differences are due to missing values.
|
203 Participants
n=296 Participants • Differences are due to missing values.
|
957 Participants
n=1512 Participants • Differences are due to missing values.
|
|
Earnings
None
|
167 Participants
n=418 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
155 Participants
n=414 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
0 Participants
n=201 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
0 Participants
n=209 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
322 Participants
n=1242 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
|
Earnings
Less than 30k
|
84 Participants
n=418 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
84 Participants
n=414 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
41 Participants
n=201 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
54 Participants
n=209 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
263 Participants
n=1242 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
|
Earnings
30K to less than 60K
|
87 Participants
n=418 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
89 Participants
n=414 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
84 Participants
n=201 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
70 Participants
n=209 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
330 Participants
n=1242 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
|
Earnings
60K or more
|
80 Participants
n=418 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
86 Participants
n=414 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
76 Participants
n=201 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
85 Participants
n=209 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
327 Participants
n=1242 Participants • Differences are due to missing values. Caregivers that had no annual earnings are included in the missing values.
|
|
English spoken at home, yes
|
433 Participants
n=459 Participants • Differences for RDP and RTP are due to missing values. Caregiver data was not collected for this measure.
|
428 Participants
n=458 Participants • Differences for RDP and RTP are due to missing values. Caregiver data was not collected for this measure.
|
—
|
—
|
861 Participants
n=917 Participants • Differences for RDP and RTP are due to missing values. Caregiver data was not collected for this measure.
|
|
Residence zone of discharge
Urban/Suburban
|
314 Participants
n=453 Participants • Differences for RDP and RTP are due to missing values. Caregiver data was not collected for this measure.
|
301 Participants
n=453 Participants • Differences for RDP and RTP are due to missing values. Caregiver data was not collected for this measure.
|
—
|
—
|
615 Participants
n=906 Participants • Differences for RDP and RTP are due to missing values. Caregiver data was not collected for this measure.
|
|
Residence zone of discharge
Rural
|
139 Participants
n=453 Participants • Differences for RDP and RTP are due to missing values. Caregiver data was not collected for this measure.
|
152 Participants
n=453 Participants • Differences for RDP and RTP are due to missing values. Caregiver data was not collected for this measure.
|
—
|
—
|
291 Participants
n=906 Participants • Differences for RDP and RTP are due to missing values. Caregiver data was not collected for this measure.
|
|
Ever used illicit drugs, yes
|
102 Participants
n=452 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
120 Participants
n=454 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
—
|
—
|
222 Participants
n=906 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
|
Ever had psychiatric hospitalization, yes
|
39 Participants
n=456 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers
|
40 Participants
n=457 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers
|
—
|
—
|
79 Participants
n=913 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers
|
|
Ever had mental health treatment, yes
|
112 Participants
n=456 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
136 Participants
n=457 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
—
|
—
|
248 Participants
n=913 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
|
Ever attempted suicide, yes
|
25 Participants
n=452 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
35 Participants
n=456 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
—
|
—
|
60 Participants
n=908 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
|
Ever served in military, yes
|
55 Participants
n=457 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
60 Participants
n=458 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
—
|
—
|
115 Participants
n=915 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
|
Living alone at discharge, yes
|
23 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
15 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
—
|
—
|
38 Participants
n=918 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
|
Discharge to facility, yes
|
89 Participants
n=462 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
89 Participants
n=463 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
178 Participants
n=925 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Spinal Cord Injury (SCI), yes
|
58 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
58 Participants
n=457 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
—
|
—
|
116 Participants
n=916 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
|
Limitations prior to injury, yes
|
222 Participants
n=457 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
209 Participants
n=458 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
431 Participants
n=915 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Alcohol use problem
|
111 Participants
n=428 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
97 Participants
n=437 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
—
|
—
|
208 Participants
n=865 Participants • Differences in RDP and RTP are due to missing values. Not collected from caregivers.
|
|
Cause of injury
Vehicle (includes pedestrian/bike)
|
232 Participants
n=456 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
248 Participants
n=457 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
480 Participants
n=913 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Cause of injury
Fall
|
168 Participants
n=456 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
146 Participants
n=457 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
314 Participants
n=913 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Cause of injury
Violence
|
40 Participants
n=456 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
41 Participants
n=457 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
81 Participants
n=913 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Cause of injury
Other
|
16 Participants
n=456 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
22 Participants
n=457 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
38 Participants
n=913 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Rehab length of stay
|
26 days
STANDARD_DEVIATION 23 • n=459 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
26 days
STANDARD_DEVIATION 26 • n=459 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
26 days
STANDARD_DEVIATION 24 • n=918 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Functional Independence Measure (FIM) Cognitive subscale at discharge
|
23 units on a scale
STANDARD_DEVIATION 6.7 • n=419 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
22.9 units on a scale
STANDARD_DEVIATION 6.7 • n=420 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
23 units on a scale
STANDARD_DEVIATION 6.7 • n=839 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Functional Independence Measure (FIM) Motor subscale at discharge
|
63.3 units on a scale
STANDARD_DEVIATION 20 • n=455 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
64.1 units on a scale
STANDARD_DEVIATION 19.7 • n=455 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
63.7 units on a scale
STANDARD_DEVIATION 19.8 • n=910 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Insurance type, yes
Medicare
|
118 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
98 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
216 Participants
n=918 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Insurance type, yes
Medicaid
|
108 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
118 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
226 Participants
n=918 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Insurance type, yes
Private/self
|
180 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
199 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
379 Participants
n=918 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Insurance type, yes
Other, Workers Comp, Charity
|
53 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
44 Participants
n=459 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
97 Participants
n=918 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Glasgow Coma Scale (GCS) Severity Score
Severe (3-8)
|
55 Participants
n=427 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
65 Participants
n=416 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
—
|
—
|
120 Participants
n=843 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
|
Glasgow Coma Scale (GCS) Severity Score
Moderate (9-12)
|
41 Participants
n=427 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
42 Participants
n=416 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
—
|
—
|
83 Participants
n=843 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
|
Glasgow Coma Scale (GCS) Severity Score
Mild (13-15)
|
159 Participants
n=427 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
127 Participants
n=416 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
—
|
—
|
286 Participants
n=843 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
|
Glasgow Coma Scale (GCS) Severity Score
Sedated/Intubated
|
172 Participants
n=427 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
182 Participants
n=416 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
—
|
—
|
354 Participants
n=843 Participants • Differences for RDP and RTP are due to missing values. For RDP - Caregivers and RTP - Caregivers, this measure is not applicable.
|
|
Severity according to time in PTA
0 to 24h (mild)
|
73 Participants
n=420 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
70 Participants
n=416 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
143 Participants
n=836 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Severity according to time in PTA
25h to 7 days (moderate)
|
43 Participants
n=420 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
47 Participants
n=416 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
90 Participants
n=836 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Severity according to time in PTA
More than 7 days (severe)
|
304 Participants
n=420 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
299 Participants
n=416 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
—
|
—
|
603 Participants
n=836 Participants • Differences in RDP and RTP are due to missing values. Not applicable to caregivers.
|
|
Country of birth, USA
|
—
|
—
|
278 Participants
n=304 Participants • Patient data was not collected for this measure. Differences for caregiver groups are due to missing values.
|
260 Participants
n=295 Participants • Patient data was not collected for this measure. Differences for caregiver groups are due to missing values.
|
538 Participants
n=599 Participants • Patient data was not collected for this measure. Differences for caregiver groups are due to missing values.
|
|
Relationship to patient
Spouse
|
—
|
—
|
117 Participants
n=304 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
114 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
231 Participants
n=599 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Relationship to patient
Parent
|
—
|
—
|
86 Participants
n=304 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
89 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
175 Participants
n=599 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Relationship to patient
Daughter or Son
|
—
|
—
|
48 Participants
n=304 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
32 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
80 Participants
n=599 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Relationship to patient
Boyfriend, Girlfriend, Fiancé, Partner
|
—
|
—
|
23 Participants
n=304 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
20 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
43 Participants
n=599 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Relationship to patient
Sibling
|
—
|
—
|
19 Participants
n=304 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
23 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
42 Participants
n=599 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Relationship to patient
Other relative
|
—
|
—
|
7 Participants
n=304 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
9 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
16 Participants
n=599 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Relationship to patient
Friend
|
—
|
—
|
1 Participants
n=304 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
4 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
5 Participants
n=599 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Relationship to patient
Other
|
—
|
—
|
3 Participants
n=304 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
4 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
7 Participants
n=599 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Living in same household, yes
|
—
|
—
|
195 Participants
n=303 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
189 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
384 Participants
n=598 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Living in private residence, yes
|
—
|
—
|
302 Participants
n=303 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
294 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
596 Participants
n=598 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Person living with caregiver
Spouse
|
—
|
—
|
188 Participants
n=303 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
191 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
379 Participants
n=598 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Person living with caregiver
Significant Other
|
—
|
—
|
32 Participants
n=303 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
27 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
59 Participants
n=598 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Person living with caregiver
Alone
|
—
|
—
|
23 Participants
n=303 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
24 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
47 Participants
n=598 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Person living with caregiver
Child/Children
|
—
|
—
|
15 Participants
n=303 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
27 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
42 Participants
n=598 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Person living with caregiver
Other relative(s)/Adult Children
|
—
|
—
|
23 Participants
n=303 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
13 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
36 Participants
n=598 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Person living with caregiver
Parent(s)
|
—
|
—
|
16 Participants
n=303 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
11 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
27 Participants
n=598 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Person living with caregiver
Siblings
|
—
|
—
|
3 Participants
n=303 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
2 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
5 Participants
n=598 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Person living with caregiver
Roommate(s) or Friend(s)
|
—
|
—
|
3 Participants
n=303 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
0 Participants
n=295 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
3 Participants
n=598 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Years (decimal) know the patient
|
—
|
—
|
30.1 years
STANDARD_DEVIATION 15.6 • n=301 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
30.0 years
STANDARD_DEVIATION 15.6 • n=289 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
30.1 years
STANDARD_DEVIATION 15.6 • n=590 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to missing values.
|
|
Years (decimal) lived in the same house
|
—
|
—
|
19.3 years
STANDARD_DEVIATION 16.3 • n=207 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to removing those that did not live in the same household and missing values.
|
18.4 years
STANDARD_DEVIATION 14.6 • n=203 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to removing those that did not live in the same household and missing values.
|
18.8 years
STANDARD_DEVIATION 15.4 • n=410 Participants • Patient data was not collected for this measure. Measure only included in/or applicable to caregiver demographics. Differences for caregiver groups are due to removing those that did not live in the same household and missing values.
|
PRIMARY outcome
Timeframe: This outcome will be assessed via self-report instrument from the patient participant 6 months after discharge from inpatient rehabilitation care.Population: Individuals with complete data for this measure.
The Participation Assessment with Recombined Tools - Objective 17 (PART-O-17) assesses participation in usual roles and social activities. There are 17 items with 0-5 response scales. Those items are combined and averaged into three domain subscale scores that range from 0-5: Productivity (3 items), Social Relations (7 items), and Out and About (7 items). The Averaged Total score, used here, is calculated by averaging the three domain scores. Higher values represent a better outcome.
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=363 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=372 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Participation Assessment With Recombined Tools - Objective 17 (PART-O-17)
|
1.30 units on a scale
Standard Deviation 0.61
|
1.33 units on a scale
Standard Deviation 0.57
|
PRIMARY outcome
Timeframe: This outcome will be assessed via self-report instrument from the patient participant 6 months after discharge from inpatient rehabilitation care.Population: Participants with complete data for this measure. This measure could only be collected from the patient (no proxy data).
A patient-reported instrument specifically created to measure the patient's perception of their health-related quality of life following TBI. The QOLIBRI scores are reported on a 0-100 scale, where 0=worst possible quality of life and 100=best possible quality of life.
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=291 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=315 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Quality of Life After Brain Injury Scale (QoLIBRI)
|
68.3 score on a scale
Standard Deviation 19.3
|
65.9 score on a scale
Standard Deviation 19.3
|
SECONDARY outcome
Timeframe: This outcome will be assessed via self-report instrument from the patient participant 3, 6, 9 and 12 months after discharge from inpatient rehabilitation care.Population: Individuals who had at least one follow-up interview.
A patient-reported instrument created to assess healthcare services utilization. This reports the number and percentage of individuals who attended at least one visit of a specialty during follow-up, regardless of whether they had been recommended and/or scheduled at discharge.
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=419 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=418 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Cornell Services Index
Rehabilitation Medicine
|
260 Participants
|
266 Participants
|
|
Cornell Services Index
Physical Therapy
|
325 Participants
|
324 Participants
|
|
Cornell Services Index
Occupational Therapy
|
262 Participants
|
283 Participants
|
|
Cornell Services Index
Primary Care Visits
|
347 Participants
|
365 Participants
|
|
Cornell Services Index
Speech Therapy
|
247 Participants
|
261 Participants
|
|
Cornell Services Index
Neurosurgery
|
162 Participants
|
156 Participants
|
|
Cornell Services Index
Neuropsychology
|
119 Participants
|
146 Participants
|
|
Cornell Services Index
Neurology
|
210 Participants
|
217 Participants
|
|
Cornell Services Index
Neuro-optometry/Neuro-ophthalmology
|
118 Participants
|
124 Participants
|
|
Cornell Services Index
Social Worker
|
83 Participants
|
88 Participants
|
|
Cornell Services Index
Psychologist/Mental health
|
104 Participants
|
120 Participants
|
|
Cornell Services Index
Vocational Counseling
|
46 Participants
|
62 Participants
|
|
Cornell Services Index
Psychiatrist
|
88 Participants
|
101 Participants
|
|
Cornell Services Index
Vision Therapy
|
32 Participants
|
31 Participants
|
SECONDARY outcome
Timeframe: This outcome was assessed via self-report instrument from the caregiver participant at 3, 6, 9 and 12 months after the patient is discharged from inpatient rehabilitation care. This is reporting the 6-month outcomes.Population: Caregiver participants with complete data for the measure at the 6 month follow-up timepoint.
A 15-item measure, each with a 7-point scale that assesses change in social functioning, emotional well-being, and physical health related to caregiving. Item scores are transformed to 1-7, then summed to provide total scale scores ranging from 15 - 105, with a higher score indicating a better outcome.
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=225 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=228 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Bakas Caregiving Outcomes Scale
|
60.1 score on a scale
Standard Deviation 15.1
|
60.0 score on a scale
Standard Deviation 13.9
|
SECONDARY outcome
Timeframe: This outcome was assessed via self-report instrument from the caregiver participant at 3, 6, 9 and 12 months after the patient is discharged from inpatient rehabilitation care. This is reporting the 6-month outcomes.Population: Caregiver participants with complete data for the measure at the 6 month follow-up timepoint.
12 item version addresses the concerns that our stakeholders feel are most important and that we feel are most relevant to our study interventions. The minimum and maximum values are 0 to 88, with 88 representing the most burden (worst outcome).
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=223 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=233 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Zarit Burden Interview
|
22.5 units on a scale
Standard Deviation 15.3
|
22.8 units on a scale
Standard Deviation 16.3
|
SECONDARY outcome
Timeframe: This outcome was assessed via self-report instrument from the caregiver participant at 3, 6, 9 and 12 months after the patient is discharged from inpatient rehabilitation care. This is reporting the 6-month outcomes.Population: Caregiver participants with complete data for the measure at the 6 month follow-up timepoint.
The SF-12 is a measure of health-related quality of life (HRQOL) and allows for 2 component scores to be determined: physical health and mental health. The scores range from 0 to 100, with higher scores indicating better physical and mental health functioning.
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=222 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=228 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Short Form 12-Item Measure (SF-12)
Physical Component
|
51.1 score on a scale
Standard Deviation 10.0
|
50.1 score on a scale
Standard Deviation 10.0
|
|
Short Form 12-Item Measure (SF-12)
Mental Component
|
46.0 score on a scale
Standard Deviation 11.8
|
46.9 score on a scale
Standard Deviation 11.7
|
SECONDARY outcome
Timeframe: This outcome was assessed via self-report instrument from the caregiver participant at 3, 6, 9 and 12 months after the patient is discharged from inpatient rehabilitation care. This is reporting the 6-month outcomes.Population: Caregiver participants with complete data for the measure at the 6 month follow-up timepoint.
A measure that assesses engagement in roles and activities apart from those related to caregiving. Raw scores are converted to scale scores, with a range of 26.2 to 65.6, with the higher score indicating better outcome.
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=228 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=234 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
PROMIS (Patient-Reported Outcomes Measurement Information System) Satisfaction With Social Roles and Activities 8a
|
51.2 score on a scale
Standard Deviation 9.0
|
50.3 score on a scale
Standard Deviation 8.5
|
SECONDARY outcome
Timeframe: This outcome was assessed via self-report instrument from the caregiver participant at 3, 6, 9 and 12 months after the patient is discharged from inpatient rehabilitation care. This is reporting the 6-month outcomes.Population: Caregiver participants with complete data for the measure at the 6 month follow-up timepoint.
A measure developed by the study team to describe the use of caregivers for individuals with TBI. The "Required Assistance" portion of the measure asks how much oversight or supervision the patient needs on a daily basis, ranging from 1) "Need someone in the room awake at all time" to 12) "Lives independently with minimal assistance". Responses were categorized into three levels with 1-8 equaling "Need supervision", 9-10 equaling "Need assistance", and 11-12 equaling "Independent".
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=227 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=232 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Time Spent Caregiving - Required Assistance
Need supervision
|
121 Participants
|
120 Participants
|
|
Time Spent Caregiving - Required Assistance
Need assistance
|
39 Participants
|
40 Participants
|
|
Time Spent Caregiving - Required Assistance
Independent
|
67 Participants
|
72 Participants
|
SECONDARY outcome
Timeframe: This outcome will be assessed longitudinally via self-report instrument from the patient participant 3,6, 9 and 12 months after discharge from inpatient rehabilitation care.Population: Total participants randomized
The Participation Assessment with Recombined Tools - Objective 17 (PART-O-17) assesses participation in usual roles and social activities. There are 17 items with 0-5 response scales. Those items are combined and averaged into three domain subscale scores that range from 0-5: Productivity (3 items), Social Relations (7 items), and Out and About (7 items). The Averaged Total score, used here, is calculated by averaging the three domain scores. Higher values represent a better outcome.
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=462 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=463 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Participation Assessment With Recombined Tools - Objective 17 (PART-O-17)
3 month
|
1.22 score on a scale
Standard Deviation 0.56
|
1.20 score on a scale
Standard Deviation 0.52
|
|
Participation Assessment With Recombined Tools - Objective 17 (PART-O-17)
6 month
|
1.30 score on a scale
Standard Deviation 0.61
|
1.33 score on a scale
Standard Deviation 0.57
|
|
Participation Assessment With Recombined Tools - Objective 17 (PART-O-17)
9 month
|
1.35 score on a scale
Standard Deviation 0.60
|
1.34 score on a scale
Standard Deviation 0.58
|
|
Participation Assessment With Recombined Tools - Objective 17 (PART-O-17)
12 month
|
1.36 score on a scale
Standard Deviation 0.61
|
1.35 score on a scale
Standard Deviation 0.58
|
SECONDARY outcome
Timeframe: This outcome will be assessed via self-report instrument from the patient participant 3, 6, 9 and 12 months after discharge from inpatient rehabilitation care.Population: Total participants randomized
A patient-reported instrument specifically created to measure the patient's perception of their health-related quality of life following TBI. The QOLIBRI scores are reported on a 0-100 scale, where 0=worst possible quality of life and 100=best possible quality of life.
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=462 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=463 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Quality of Life After Brain Injury Scale (QoLIBRI)
3 month
|
67.5 score on a scale
Standard Deviation 18.1
|
65.1 score on a scale
Standard Deviation 18.1
|
|
Quality of Life After Brain Injury Scale (QoLIBRI)
6 month
|
68.3 score on a scale
Standard Deviation 18.1
|
65.9 score on a scale
Standard Deviation 17.8
|
|
Quality of Life After Brain Injury Scale (QoLIBRI)
9 month
|
68.3 score on a scale
Standard Deviation 19.9
|
66.0 score on a scale
Standard Deviation 19.0
|
|
Quality of Life After Brain Injury Scale (QoLIBRI)
12 month
|
68.3 score on a scale
Standard Deviation 20.2
|
65.8 score on a scale
Standard Deviation 19.3
|
SECONDARY outcome
Timeframe: This outcome will be assessed via self-report instrument from the patient participant 6 and 12 months after discharge from inpatient rehabilitation care. 6-month outcomes are reported.Population: Participants with complete data for this measure at 6 months post-discharge.
A measure developed by the study team to assess satisfaction with health care received by the patient participant. Patients, caregivers, both, or another appropriate proxy could rate their satisfaction with different domain's of the patient's care on a 1-7 scale, where 1 = Very dissatisfied, 7 = Very satisfied, and 4 = Neutral. Higher scores indicate higher satisfaction (better outcome).
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=332 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=346 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Satisfaction With Care
Get help coordinating healthcare
|
5.69 units on a scale
Standard Deviation 1.71
|
5.74 units on a scale
Standard Deviation 1.62
|
|
Satisfaction With Care
Attend appointments
|
6.05 units on a scale
Standard Deviation 1.45
|
5.99 units on a scale
Standard Deviation 1.55
|
|
Satisfaction With Care
Get answers about healthcare
|
5.76 units on a scale
Standard Deviation 1.59
|
5.81 units on a scale
Standard Deviation 1.5
|
|
Satisfaction With Care
Connect with community resources/services
|
5.01 units on a scale
Standard Deviation 1.83
|
5.27 units on a scale
Standard Deviation 1.78
|
|
Satisfaction With Care
Receive help when it's needed
|
5.72 units on a scale
Standard Deviation 1.75
|
5.86 units on a scale
Standard Deviation 1.62
|
SECONDARY outcome
Timeframe: This outcome was assessed via self-report instrument from both patient and caregiver participants (if applicable) randomized to the RTP group 6 months after discharge from inpatient rehabilitation care (if they consented to complete the survey).Population: The 16 patients and caregivers who jointly completed the survey are represented in both groups, however the data table shows data for the combined surveys only in the patient column, therefore the number of caregivers represented in the caregiver column is only 104.
A measure developed by the study team to assess satisfaction with RTP (intervention), measured through Likert-scaled and open-ended questions.
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=175 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=120 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
RTP Satisfaction Survey
RTP helped with resources connections after discharge · Not at all
|
5 Participants
|
3 Participants
|
|
RTP Satisfaction Survey
RTP helped with resources connections after discharge · A little bit
|
14 Participants
|
5 Participants
|
|
RTP Satisfaction Survey
RTP helped with resources connections after discharge · Moderately
|
29 Participants
|
13 Participants
|
|
RTP Satisfaction Survey
RTP helped with resources connections after discharge · A lot
|
40 Participants
|
24 Participants
|
|
RTP Satisfaction Survey
RTP helped with resources connections after discharge · Extremely
|
68 Participants
|
57 Participants
|
|
RTP Satisfaction Survey
RTP helped with resources connections after discharge · NA/Not Answered
|
19 Participants
|
2 Participants
|
|
RTP Satisfaction Survey
RTP helped with practical, day-to-day adjustment to life with a brain injury · Not at all
|
6 Participants
|
3 Participants
|
|
RTP Satisfaction Survey
RTP helped with practical, day-to-day adjustment to life with a brain injury · A little bit
|
13 Participants
|
5 Participants
|
|
RTP Satisfaction Survey
RTP helped with practical, day-to-day adjustment to life with a brain injury · Moderately
|
33 Participants
|
15 Participants
|
|
RTP Satisfaction Survey
RTP helped with practical, day-to-day adjustment to life with a brain injury · A lot
|
57 Participants
|
23 Participants
|
|
RTP Satisfaction Survey
RTP helped with practical, day-to-day adjustment to life with a brain injury · Extremely
|
54 Participants
|
52 Participants
|
|
RTP Satisfaction Survey
RTP helped with practical, day-to-day adjustment to life with a brain injury · NA/Not Answered
|
12 Participants
|
6 Participants
|
|
RTP Satisfaction Survey
RTP helped with emotional adjustment to life with a brain injury · Not at all
|
12 Participants
|
4 Participants
|
|
RTP Satisfaction Survey
RTP helped with emotional adjustment to life with a brain injury · A little bit
|
12 Participants
|
3 Participants
|
|
RTP Satisfaction Survey
RTP helped with emotional adjustment to life with a brain injury · Moderately
|
33 Participants
|
11 Participants
|
|
RTP Satisfaction Survey
RTP helped with emotional adjustment to life with a brain injury · A lot
|
44 Participants
|
29 Participants
|
|
RTP Satisfaction Survey
RTP helped with emotional adjustment to life with a brain injury · Extremely
|
63 Participants
|
54 Participants
|
|
RTP Satisfaction Survey
RTP helped with emotional adjustment to life with a brain injury · NA/Not Answered
|
11 Participants
|
3 Participants
|
|
RTP Satisfaction Survey
RTP helped accomplish the things you wanted to do · Not at all
|
8 Participants
|
4 Participants
|
|
RTP Satisfaction Survey
RTP helped accomplish the things you wanted to do · A little bit
|
14 Participants
|
7 Participants
|
|
RTP Satisfaction Survey
RTP helped accomplish the things you wanted to do · Moderately
|
30 Participants
|
21 Participants
|
|
RTP Satisfaction Survey
RTP helped accomplish the things you wanted to do · A lot
|
51 Participants
|
25 Participants
|
|
RTP Satisfaction Survey
RTP helped accomplish the things you wanted to do · Extremely
|
53 Participants
|
42 Participants
|
|
RTP Satisfaction Survey
RTP helped accomplish the things you wanted to do · NA/Not Answered
|
19 Participants
|
5 Participants
|
|
RTP Satisfaction Survey
It was valuable to talk with someone who understands TBI · Not at all
|
3 Participants
|
3 Participants
|
|
RTP Satisfaction Survey
It was valuable to talk with someone who understands TBI · A little bit
|
4 Participants
|
0 Participants
|
|
RTP Satisfaction Survey
It was valuable to talk with someone who understands TBI · Moderately
|
10 Participants
|
3 Participants
|
|
RTP Satisfaction Survey
It was valuable to talk with someone who understands TBI · A lot
|
30 Participants
|
12 Participants
|
|
RTP Satisfaction Survey
It was valuable to talk with someone who understands TBI · Extremely
|
120 Participants
|
83 Participants
|
|
RTP Satisfaction Survey
It was valuable to talk with someone who understands TBI · NA/Not Answered
|
8 Participants
|
3 Participants
|
SECONDARY outcome
Timeframe: This outcome was assessed via self-report instrument from the caregiver participant at 3, 6, 9 and 12 months after the patient is discharged from inpatient rehabilitation care. This is reporting the 6-month outcomes.Population: Caregivers who reported the patient in the "Need supervision" or "Need assistance" category for Required Assistance measure.
The "Reason for Assistance" measure asks which category captures the reason the patient cannot be alone (if in the "Need supervision" or "Need assistance" category for Required Assistance).
Outcome measures
| Measure |
Rehabilitation Discharge Plan
n=159 Participants
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=161 Participants
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
|---|---|---|
|
Time Spent Caregiving - Reason for Assistance
Other
|
5 Participants
|
4 Participants
|
|
Time Spent Caregiving - Reason for Assistance
Cognition/Behavior
|
39 Participants
|
42 Participants
|
|
Time Spent Caregiving - Reason for Assistance
Physical function
|
33 Participants
|
32 Participants
|
|
Time Spent Caregiving - Reason for Assistance
Both
|
82 Participants
|
83 Participants
|
Adverse Events
Rehabilitation Discharge Plan
Rehabilitation Transition Plan
Rehabilitation Discharge Plan - Caregivers
Rehabilitation Transition Plan - Caregivers
Death Prior to Randomization
Serious adverse events
| Measure |
Rehabilitation Discharge Plan
n=462 participants at risk
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=463 participants at risk
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
Rehabilitation Discharge Plan - Caregivers
n=296 participants at risk
Caregivers of patients randomized to the Rehabilitation Discharge Plan (RDP) group
|
Rehabilitation Transition Plan - Caregivers
n=295 participants at risk
Caregivers of patients randomized to the Rehabilitation Transition Plan (RTP) group
|
Death Prior to Randomization
n=11 participants at risk
Patient who expired after enrollment but prior to randomization.
|
|---|---|---|---|---|---|
|
Blood and lymphatic system disorders
Blood and lymphatic system disorders
|
0.22%
1/462 • Number of events 2 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/463 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Cardiac disorders
Cardiac disorders
|
0.65%
3/462 • Number of events 3 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
2.6%
12/463 • Number of events 16 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Gastrointestinal disorders
Gastrointestinal disorders
|
1.5%
7/462 • Number of events 8 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.86%
4/463 • Number of events 4 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
General disorders
General disorders
|
5.4%
25/462 • Number of events 25 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
5.8%
27/463 • Number of events 31 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.68%
2/296 • Number of events 2 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.0%
3/295 • Number of events 3 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Hepatobiliary disorders
Hepatobiliary disorders
|
0.00%
0/462 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.43%
2/463 • Number of events 3 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/296 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Immune system disorders
Immune system disorders
|
0.22%
1/462 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/463 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Infections and infestations
Infections and infestations
|
6.5%
30/462 • Number of events 37 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
5.4%
25/463 • Number of events 31 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/295 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Injury, poisoning and procedural complications
Injury, poisoning and procedural complications
|
5.2%
24/462 • Number of events 29 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
4.3%
20/463 • Number of events 20 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/295 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Metabolism and nutrition disorders
Metabolism and nutrition disorders
|
1.1%
5/462 • Number of events 7 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.1%
5/463 • Number of events 5 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/295 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Musculoskeletal and connective tissue disorders
Musculoskeletal and connective tissue disorders
|
0.22%
1/462 • Number of events 2 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.86%
4/463 • Number of events 5 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/295 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Neoplasms benign, malignant and unspecified (including cysts and polyps)
|
0.43%
2/462 • Number of events 2 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/463 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Nervous system disorders
Nervous system disorders
|
7.6%
35/462 • Number of events 53 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
10.4%
48/463 • Number of events 71 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Psychiatric disorders
Psychiatric disorders
|
2.4%
11/462 • Number of events 12 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
3.7%
17/463 • Number of events 18 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Renal and urinary disorders
Renal and urinary disorders
|
0.22%
1/462 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.1%
5/463 • Number of events 5 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory, thoracic and mediastinal disorders
|
1.7%
8/462 • Number of events 11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.9%
9/463 • Number of events 11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Skin and subcutaneous tissue disorders
Skin and subcutaneous tissue disorders
|
0.00%
0/462 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.43%
2/463 • Number of events 5 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Surgical and medical procedures
Surgical and medical procedures
|
1.7%
8/462 • Number of events 9 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.9%
9/463 • Number of events 10 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Vascular disorders
Vascular disorders
|
1.3%
6/462 • Number of events 6 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.9%
9/463 • Number of events 13 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/296 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.68%
2/295 • Number of events 2 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
Other adverse events
| Measure |
Rehabilitation Discharge Plan
n=462 participants at risk
Commission on Accreditation of Rehabilitation Facilities (CARF) standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury, including patient and family education, written discharge care instructions, and telephone follow up from a clinical provider.
Rehabilitation Discharge Plan: CARF standards for discharge following an inpatient rehabilitation stay for a traumatic brain injury. This approach may include the following:
1. patient and family education about TBI, both general and individualized to each person's symptoms and level of function, as well as education on medications and symptoms to monitor following discharge;
2. written discharge care instructions, including recommended appointments with primary care, rehabilitation medicine and outpatient therapies, and medication list which are reviewed with the patient and family prior to discharge; and
3. a phone call from an inpatient care provider within a few days of discharge to address any immediate problems and ensure that equipment has arrived, medications are being taken, etc.
|
Rehabilitation Transition Plan
n=463 participants at risk
Approximately 12 scheduled contacts from a TBI care manager 6 months following discharge in addition to the CARF standards for discharge.
Rehabilitation Transition Plan: Participants and their caregivers (if applicable) randomized to the Rehabilitation Transition Plan group will receive up to 12 scheduled contacts 6 months post-discharge from a TBI care manager familiar with the care and resource networks at the respective sites. The contacts will at minimum be by telephone, although a HIPAA-compliant video conferencing option will also be available.
The content of these contacts will include:
1. Particularly in the first few calls, review of discharge plans and assistance and/or directive problem-solving around any obstacles to following discharge plans;
2. Assessment of unmet needs, developed into a standard checklist of areas of need that are relevant to TBI, culled from literature on need fulfillment in this population.
|
Rehabilitation Discharge Plan - Caregivers
n=296 participants at risk
Caregivers of patients randomized to the Rehabilitation Discharge Plan (RDP) group
|
Rehabilitation Transition Plan - Caregivers
n=295 participants at risk
Caregivers of patients randomized to the Rehabilitation Transition Plan (RTP) group
|
Death Prior to Randomization
n=11 participants at risk
Patient who expired after enrollment but prior to randomization.
|
|---|---|---|---|---|---|
|
Cardiac disorders
Cardiac disorders
|
0.00%
0/462 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.65%
3/463 • Number of events 3 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Endocrine disorders
Endocrine disorders
|
0.00%
0/462 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/463 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/295 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Eye disorders
Eye disorders
|
0.00%
0/462 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.43%
2/463 • Number of events 2 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Gastrointestinal disorders
Gastrointestinal disorders
|
1.5%
7/462 • Number of events 7 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
2.8%
13/463 • Number of events 14 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/296 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
General disorders
General disorders
|
1.1%
5/462 • Number of events 5 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
2.6%
12/463 • Number of events 14 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Hepatobiliary disorders
Hepatobiliary disorders
|
0.00%
0/462 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.43%
2/463 • Number of events 2 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Immune system disorders
Immune system disorders
|
0.22%
1/462 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/463 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Infections and infestations
Infections and infestations
|
4.5%
21/462 • Number of events 23 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
6.0%
28/463 • Number of events 32 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.7%
5/296 • Number of events 5 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
2.4%
7/295 • Number of events 7 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Injury, poisoning and procedural complications
Injury, poisoning and procedural complications
|
9.1%
42/462 • Number of events 46 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
11.7%
54/463 • Number of events 65 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.68%
2/296 • Number of events 2 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.0%
3/295 • Number of events 3 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Metabolism and nutrition disorders
Metabolism and nutrition disorders
|
1.1%
5/462 • Number of events 6 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.65%
3/463 • Number of events 3 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Musculoskeletal and connective tissue disorders
Musculoskeletal and connective tissue disorders
|
1.5%
7/462 • Number of events 8 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
2.6%
12/463 • Number of events 15 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/296 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/295 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Neoplasms benign, malignant and unspecified (including cysts and polyps)
|
0.22%
1/462 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.43%
2/463 • Number of events 2 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Nervous system disorders
Nervous system disorders
|
3.5%
16/462 • Number of events 18 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
4.5%
21/463 • Number of events 24 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Psychiatric disorders
Psychiatric disorders
|
1.1%
5/462 • Number of events 7 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.5%
7/463 • Number of events 9 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/296 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Renal and urinary disorders
Renal and urinary disorders
|
0.22%
1/462 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.65%
3/463 • Number of events 5 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.34%
1/295 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Reproductive system and breast disorders
Reproductive system and breast disorders
|
0.22%
1/462 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.22%
1/463 • Number of events 1 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory, thoracic and mediastinal disorders
|
1.7%
8/462 • Number of events 8 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.5%
7/463 • Number of events 7 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Skin and subcutaneous tissue disorders
Skin and subcutaneous tissue disorders
|
0.43%
2/462 • Number of events 2 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.43%
2/463 • Number of events 3 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Surgical and medical procedures
Surgical and medical procedures
|
0.65%
3/462 • Number of events 3 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.1%
5/463 • Number of events 5 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
|
Vascular disorders
Vascular disorders
|
0.87%
4/462 • Number of events 4 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
1.7%
8/463 • Number of events 8 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/296 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/295 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
0.00%
0/11 • Adverse event data were collected throughout the participant's participation, approximately 12 months.
Adverse events were recorded when brought up by participants during data collection and intervention activities, and categorized as Serious or non-serious. SAE's were categorized into five categories: Death, life threatening, hospitalization - initial or prolonged, disability/incapacity, or required intervention to prevent permanent impairment. Each event had a brief description of the nature collected. No events were determined to be related to study activities.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place